O
Orchestra BioMed Holdings, Inc. (OBIO)
NGM – Real Time Price. Currency in USD
4.26
-0.23 (-5.12%)
At close: Mar 27, 2026, 4:00 PM EDT
4.09
-0.17 (-4.08%)
After-hours: Mar 27, 2026, 5:15 PM EDT

NGM – Real Time Price. Currency in USD
4.26
-0.23 (-5.12%)
At close: Mar 27, 2026, 4:00 PM EDT
4.09
-0.17 (-4.08%)
After-hours: Mar 27, 2026, 5:15 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.45 | 6.05 | 10 | |
| Quick ratio | 6.43 | 5.63 | 10 | |
| Debt to Equity | 0.51 | 0.30 | 7.0 | |
| Debt to Assets | 0.28 | 1.04 | 7.0 | |
| Interest coverage | 8.85 | -16.91 | 10 | |
| Weighted average score | 8.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 4M | 3M | 3M | 33M | 33M |
| Gross Profit | 3M | 2M | 2M | 33M | 33M |
| Operating Income | -33M | -52M | -64M | -52M | -52M |
| Net Income | -34M | -49M | -61M | -53M | -53M |
| EBITDA | -32M | -51M | -64M | -51M | -51M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 18.38 | 13.88 | 8.5 |
| Next quarter | -69.8 | 13.23 | 4.5 |
| Current year | -93.87 | -56.87 | 1.0 |
| Next year | -6.35 | 4.55 | 2.5 |
| Weighted average score | 4.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 3490.82 | 129.98 | 129.56 | 84.5 | 10 |
| Y/Y | 12120.16 | 138.66 | 128.15 | 83.12 | 10 |
| 3y average | 380.98 | -18.9 | 36.95 | -20.63 | 5.5 |
| 5y average | 628.19 | -1789.65 | 36.95 | -2187.6 | 5.5 |
| Weighted average score | 7.8 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $34.7M significantly exceed its total debt $32.4M, ensuring strong financial flexibility
Total current assets $107.9M exceed Total current liabilities $16.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.5) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (9x) indicates the company easily manages its debt payments
Negative free cash flow -$2.3M limits the company's ability to reinvest or pay down debt